<code id='62786B5093'></code><style id='62786B5093'></style>
    • <acronym id='62786B5093'></acronym>
      <center id='62786B5093'><center id='62786B5093'><tfoot id='62786B5093'></tfoot></center><abbr id='62786B5093'><dir id='62786B5093'><tfoot id='62786B5093'></tfoot><noframes id='62786B5093'>

    • <optgroup id='62786B5093'><strike id='62786B5093'><sup id='62786B5093'></sup></strike><code id='62786B5093'></code></optgroup>
        1. <b id='62786B5093'><label id='62786B5093'><select id='62786B5093'><dt id='62786B5093'><span id='62786B5093'></span></dt></select></label></b><u id='62786B5093'></u>
          <i id='62786B5093'><strike id='62786B5093'><tt id='62786B5093'><pre id='62786B5093'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:fashion    Page View:5975
          Tome cofounders Jonathan Gootenberg, left, and Omar Abudayyeh, a scientific team that's trying to reinvent gene editing for a new era of biotech innovation.
          Suzanne Kreiter/Globe staff

          WATERTOWN — Their brainstorming began in an MIT class in 2010 when the eager undergrads shot each other emails about how to solve a bioengineering equation. It has continued for 14 years over sushi dinners, between Marvel movies, and during rowing-machine workouts.

          Together, Omar Abudayyeh, 33, and Jonathan Gootenberg, 32, have probed the mysteries of genomic editing and COVID detection. They co-published 10 scientific papers, helped launch two medical-diagnostic companies, and cofounded a Watertown startup, Tome Biosciences, that reengineers genes and cells to cure diseases. They also run the Abudayyeh-Gootenberg Lab at Harvard.

          advertisement

          Gootenberg and Abudayyeh are an unusual pair, two scientists — a Jewish American and a Palestinian American — who prefer working together in a field that often draws solitary researchers and rewards individual achievement.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          Hepatitis C has a cure — but many Americans still lack access to it
          Hepatitis C has a cure — but many Americans still lack access to it

          AdobeIn2005,NickVoyleswasdiagnosedwithhepatitisCafterbeingreleasedfromfiveyearsofincarceration.Anurs

          read more
          A letter from the executive editor: The 2023 STATUS List
          A letter from the executive editor: The 2023 STATUS List

          Aftermonthsofvigorousdeliberations,I’mthrilledtoannounceour2023STATUSList—thedefinitiverosterofleade

          read more
          23andMe had bad news about my health. I wish a person had delivered it
          23andMe had bad news about my health. I wish a person had delivered it

          ERICBARADAT/AFP/GettyImagesLastsummer,IthoughtitmightbefuntohavemyDNAanalyzed.Twocompanies,23andMean

          read more

          Skip the lead apron during X

          AdobeThinkbacktothelasttimeyouhadanX-ray:Theradiologictechnologistprobablyplacedaleadapronoverpartof